Literature DB >> 7130575

Symptomatic pyelonephritis in elderly men.

R Gleckman, N Blagg, D Hibert, A Hall, M Crowley, A Pritchard, W Warren.   

Abstract

A prospective study was carried out of the clinical, laboratory, radiologic and therapeutic features of acute, symptomatic, bacterial pyelonephritis as experienced by 12 consecutive elderly, noncatheterized men who required hospitalization. In spite of the advanced ages of the men and the inordinate frequency of bacteremia and septic shock, no patient died. "Appropriate" antibiotic therapy, supportive treatment, and, as importantly, a lack of associated "imminently" or "ultimately" fatal illnesses contributed to the 100 per cent survival rate. Guidelines are provided for the diagnostic evaluation and antibiotic therapy of community-acquired pyelonephritis in elderly men.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130575     DOI: 10.1111/j.1532-5415.1982.tb01981.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  4 in total

Review 1.  Treatment duration for urinary tract infections in adults.

Authors:  R A Gleckman
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

2.  Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene.

Authors:  F K Bahrani; H L Mobley
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

3.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression.

Authors:  F K Bahrani; H L Mobley
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.